Literature DB >> 24622384

Echocardiographic screening for rheumatic heart disease in high and low risk Australian children.

Kathryn Roberts1, Graeme Maguire, Alex Brown, David Atkinson, Bo Reményi, Gavin Wheaton, Andrew Kelly, Raman K Kumar, Jiunn-Yih Su, Jonathan R Carapetis.   

Abstract

BACKGROUND: Echocardiographic screening for rheumatic heart disease (RHD) is becoming more widespread, but screening studies to date have used different echocardiographic definitions. The World Heart Federation has recently published new criteria for the echocardiographic diagnosis of RHD. We aimed to establish the prevalence of RHD in high-risk Indigenous Australian children using these criteria and to compare the findings with a group of Australian children at low risk for RHD. METHODS AND
RESULTS: Portable echocardiography was performed on high-risk Indigenous children aged 5 to 15 years living in remote communities of northern Australia. A comparison group of low-risk, non-Indigenous children living in urban centers was also screened. Echocardiograms were reported in a standardized, blinded fashion. Of 3946 high-risk children, 34 met World Heart Federation criteria for definite RHD (prevalence, 8.6 per 1000 [95% confidence interval, 6.0-12.0]) and 66 for borderline RHD (prevalence, 16.7 per 1000 [95% confidence interval, 13.0-21.2]). Of 1053 low-risk children, none met the criteria for definite RHD, and 5 met the criteria for borderline RHD. High-risk children were more likely to have definite or borderline RHD than low-risk children (adjusted odds ratio, 5.7 [95% confidence interval, 2.3-14.1]; P<0.001).
CONCLUSIONS: The prevalence of definite RHD in high-risk Indigenous Australian children approximates what we expected in our population, and no definite RHD was identified in the low-risk group. This study suggests that definite RHD, as defined by the World Heart Federation criteria, is likely to represent true disease. Borderline RHD was identified in children at both low and high risk, highlighting the need for longitudinal studies to evaluate the clinical significance of this finding.

Entities:  

Keywords:  echocardiography; mass screening; pediatrics; rheumatic heart disease

Mesh:

Year:  2014        PMID: 24622384     DOI: 10.1161/CIRCULATIONAHA.113.003495

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  29 in total

1.  Echocardiographic screening for rheumatic heart disease-some answers, but questions remain.

Authors:  Marc G W Rémond; Graeme P Maguire
Journal:  Transl Pediatr       Date:  2015-07

2.  Echocardiographic screening of 4107 Nigerian school children for rheumatic heart disease.

Authors:  Ekanem N Ekure; Casmir Amadi; Ogochukwu Sokunbi; Nnenna Kalu; Akinsanya Olusegun-Joseph; Oyewole Kushimo; Olayinka Hassan; Desmond Ikebudu; Sophia Onyia; Chinonso Onwudiwe; Victor Nwankwo; Remi Akinwunmi; Fukpode Awusa; Zainab Akere; Olaolu Dele-Salawu; Elizabeth Ajayi; Olagoke Ale; Dorothy Muoneke; Maximillian Muenke; Paul Kruszka; Andrea Beaton; Craig Sable; Adebowale Adeyemo
Journal:  Trop Med Int Health       Date:  2019-04-08       Impact factor: 2.622

Review 3.  Prescribing for people with acute rheumatic fever.

Authors:  Anna P Ralph; Sara Noonan; Claire Boardman; Catherine Halkon; Bart J Currie
Journal:  Aust Prescr       Date:  2017-04-03

4.  The utility of handheld echocardiography for early rheumatic heart disease diagnosis: a field study.

Authors:  Andrea Beaton; Jimmy C Lu; Twalib Aliku; Peter Dean; Lasya Gaur; Jacqueline Weinberg; Justin Godown; Peter Lwabi; Grace Mirembe; Emmy Okello; Allison Reese; Ashley Shrestha-Astudillo; Tyler Bradley-Hewitt; Janet Scheel; Catherine Webb; Robert McCarter; Greg Ensing; Craig Sable
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-01-05       Impact factor: 6.875

5.  Decreased Prevalence of Rheumatic Heart Disease Confirmed Among HIV-positive Youth.

Authors:  Ian W Hovis; Judith Namuyonga; Grace P Kisitu; Emma Ndagire; Emmy Okello; Chris T Longenecker; Amy Sanyahumbi; Craig A Sable; Daniel J Penny; Peter Lwabi; Adeodata R Kekitiinwa; Andrea Beaton
Journal:  Pediatr Infect Dis J       Date:  2019-04       Impact factor: 2.129

Review 6.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

Review 7.  Sex Differences in Pediatric Rheumatology.

Authors:  Marco Cattalini; Martina Soliani; Maria Costanza Caparello; Rolando Cimaz
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

8.  Bmi1 and BRG1 drive myocardial repair by regulating cardiac stem cell function in acute rheumatic heart disease.

Authors:  Pingxi Xiao; Kai Zhang; Zhiwen Tao; Niannian Liu; Bangshun Ge; Min Xu; Xinzheng Lu
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

9.  Screening-detected rheumatic heart disease can progress to severe disease.

Authors:  Daniel Engelman; Gavin R Wheaton; Reapi L Mataika; Joseph H Kado; Samantha M Colquhoun; Bo Remenyi; Andrew C Steer
Journal:  Heart Asia       Date:  2016-11-28

10.  Brief Report: Prevalence of Latent Rheumatic Heart Disease Among HIV-Infected Children in Kampala, Uganda.

Authors:  Brigette Gleason; Grace Mirembe; Judith Namuyonga; Emmy Okello; Peter Lwabi; Irene Lubega; Sulaiman Lubega; Victor Musiime; Cissy Kityo; Robert A Salata; Chris T Longenecker
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.